Literature DB >> 20972725

Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report.

L Zinnamosca1, L Petramala, D Cotesta, C Marinelli, S Sciomer, G Cavallaro, A Ciardi, R Massa, G De Toma, S Filetti, C Letizia.   

Abstract

Primary aldosteronism (PA) with synchronous carcinoid syndrome is extremely rare occurrence. In this article, we describe a case of PA due to adrenocortical adenoma ("aldosteronoma") and concurrent malignant carcinoid tumor of ileum. The patient was treated with synchronous right adrenalectomy and resection of the ileum. This case is an example of concomitant presence of two types of tumors, effectively managed surgically. We report a case of a nonclassical form of multiple endocrine neoplasia type 1 (MEN 1) syndrome.

Entities:  

Mesh:

Year:  2010        PMID: 20972725     DOI: 10.1007/s12020-010-9394-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

1.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

2.  Consensus guidelines for the management of patients with digestive neuroendocrine tumors--well-differentiated jejunal-ileal tumor/carcinoma.

Authors:  Barbro Eriksson; Günter Klöppel; Eric Krenning; Hakan Ahlman; Ursula Plöckinger; Bertram Wiedenmann; Rudolf Arnold; Christoph Auernhammer; Meike Körner; Guido Rindi; Stefan Wildi
Journal:  Neuroendocrinology       Date:  2007-12-12       Impact factor: 4.914

3.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

Review 4.  Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.

Authors:  S S Guo; M P Sawicki
Journal:  Mol Endocrinol       Date:  2001-10

Review 5.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

Review 6.  Carcinoid tumors.

Authors:  Scott N Pinchot; Kyle Holen; Rebecca S Sippel; Herbert Chen
Journal:  Oncologist       Date:  2008-12-17

Review 7.  Complications of midgut carcinoid tumors and carcinoid syndrome.

Authors:  Anouk N A van der Horst-Schrivers; A N Machteld Wymenga; Thera P Links; Pax H B Willemse; Ido P Kema; Elisabeth G E de Vries
Journal:  Neuroendocrinology       Date:  2004       Impact factor: 4.914

8.  Diagnosis of hypokalemia: a problem-solving approach to clinical cases.

Authors:  Farahnak Assadi
Journal:  Iran J Kidney Dis       Date:  2008-07       Impact factor: 0.892

Review 9.  Multiple endocrine neoplasms.

Authors:  Alberto Falchetti; Francesca Marini; Ettore Luzi; Francesco Tonelli; Maria Luisa Brandi; Maria Luisa Brandt
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

Review 10.  Primary aldosteronism: an update on screening, diagnosis and treatment.

Authors:  Gian Paolo Rossi; Achille Cesare Pessina; Anthony M Heagerty
Journal:  J Hypertens       Date:  2008-04       Impact factor: 4.844

View more
  1 in total

1.  Predictors of malignancy in primary aldosteronism.

Authors:  Ayman Agha; Matthias Hornung; Igors Iesalnieks; Andreas Schreyer; Ernst Michael Jung; Assad Haneya; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2013-09-19       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.